Target enrollment met in the MISSION Phase 2 trial evaluating KZR-616 for lupus nephritis First patient dosed in Phase 1 trial of KZR-261 for the treatment of advanced solid tumor malignancies Company to host virtual Investor and Analyst Day on Monday, November 15, 2021, at 4:30 p.m. ET to discuss… Read More..

Common Shares will Continue to Trade under Ticker “BLBX” DALLAS--(BUSINESS WIRE)--Blackboxstocks, Inc. (Nasdaq: BLBX) (“Blackbox” or the “Company”), a financial technology and social media hybrid platform offering real-time proprietary analytics for stock and options traders of all levels, today announced the pricing of an underwritten public offering of 2,400,000 shares… Read More..

Reduced Costs & Other Positive Impacts from Financial Restructuring Benefiting Results SAN FRANCISCO, CA, Nov. 10, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire -- American Shared Hospital Services (NYSE American: AMS) (the "Company"), a leading provider of turnkey technology solutions for stereotactic radiosurgery and advanced radiation therapy equipment and services, today announced financial… Read More..